Clinical Trials in Rhode Island

Rhode Island is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Rhode Island and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 65 actively recruiting studies with Rhode Island sites out of 65 registered in total. The busiest research areas in Rhode Island are Ulcerative Colitis, Malignant Solid Neoplasm, Advanced Solid Tumor. Leading sponsors running trials in the state include Rhode Island Hospital, National Cancer Institute (NCI), SWOG Cancer Research Network. By stage, Rhode Island trials break down as Phase 1 (11), Phase 2 (13), Phase 3 (25), Phase 4 (3).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials

65

Recruiting Now

65

← Back to US Map

Top Conditions in Rhode Island

Ulcerative Colitis (2)Malignant Solid Neoplasm (2)Advanced Solid Tumor (2)Sickle Cell Disease (2)Acute Myeloid Leukemia (2)Endometrial Cancer (2)Anatomic Stage IV Breast Cancer AJCC v8 (1)Estrogen Receptor Positive (1)HER2/Neu Negative (1)Progesterone Receptor Positive (1)Prognostic Stage IV Breast Cancer AJCC v8 (1)Elevated CA15-3 or CEA or CA27-29 (1)

Frequently Asked Questions — Clinical Trials in Rhode Island

How many clinical trials are currently recruiting in Rhode Island?

ClinicalMetric currently tracks 65 actively recruiting clinical trials with at least one location in Rhode Island. The total number of registered studies—including active but not currently enrolling trials—is 65. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.

What types of clinical trials are available in Rhode Island?

Rhode Island hosts clinical trials across a broad range of medical conditions, including Ulcerative Colitis, Malignant Solid Neoplasm, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Rhode Island serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.

How do I join a clinical trial near me in Rhode Island?

To join a clinical trial in Rhode Island, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Rhode Island maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Clinical Trials in Rhode Island

Frequently Asked Questions — Clinical Trials in Rhode Island

Recruiting Trials in Rhode Island